These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 1337553

  • 61. Multicenter randomized study of two once daily regimens in the initial management of community-acquired respiratory tract infections in 163 children: azithromycin versus ceftibuten.
    Galova K, Sufliarska S, Kukova Z, Danisovicova A, Hrachova I, Grausova S, Marinova I, Krizan S, Stopkova K, Stahorska A, Durcanska K, Raskova J, Krupova I, Krcméry V.
    Chemotherapy; 1996; 42(3):231-4. PubMed ID: 8983893
    [Abstract] [Full Text] [Related]

  • 62. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.
    Vergis EN, Indorf A, File TM, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, YU VL.
    Arch Intern Med; 2000 May 08; 160(9):1294-300. PubMed ID: 10809032
    [Abstract] [Full Text] [Related]

  • 63. Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases.
    Treadway G, Reisman A.
    Int J Antimicrob Agents; 2001 Nov 08; 18(5):427-31. PubMed ID: 11711256
    [Abstract] [Full Text] [Related]

  • 64. [Ergoferon liquid dosage form--efficacious and safe treatment for childhood acute respiratory infections. Interim outcomes of a multi-center, randomized, double-blind, placebo-controlled clinical trial].
    Geppe NA, Kondiurina EG, Galustian AN, Pak TE, Bal'tserovich NB, Zhiglinskaia OV, Kamaev AV, Lazareva SG, Laléko SL, Mel'nikova IM, Perminova OA, Sabitov AU.
    Antibiot Khimioter; 2014 Nov 08; 59(5-6):6-14. PubMed ID: 25552038
    [Abstract] [Full Text] [Related]

  • 65. [Evaluation of the clinical efficacy of azithromycin in acute respiratory infections in children].
    Bottaro G, Rotolo N, Bonforte S, Bucchieri R, De Luca P, Ficarra G, Gulino A, Melillo P, Nicosia A, Prestifilippo F.
    Clin Ter; 1994 Jul 08; 145(7):35-9. PubMed ID: 7955949
    [Abstract] [Full Text] [Related]

  • 66. Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infections.
    Balmes P, Clerc G, Dupont B, Labram C, Pariente R, Poirier R.
    Eur J Clin Microbiol Infect Dis; 1991 May 08; 10(5):437-9. PubMed ID: 1651860
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections.
    O'Doherty B.
    J Antimicrob Chemother; 1996 Jun 08; 37 Suppl C():71-81. PubMed ID: 8818848
    [Abstract] [Full Text] [Related]

  • 69. Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
    Adam D, Glaser-Caldow E, Wachter J, Brueckner OJ, Hein J, Kroemer B, Hirsch J.
    Clin Ther; 2001 Apr 08; 23(4):585-95. PubMed ID: 11354392
    [Abstract] [Full Text] [Related]

  • 70. Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis.
    Casiano RR.
    Am J Med; 1991 Sep 12; 91(3A):27S-30S. PubMed ID: 1656739
    [Abstract] [Full Text] [Related]

  • 71. Azithromycin: the first azalide antibiotic.
    Ballow CH, Amsden GW.
    Ann Pharmacother; 1992 Oct 12; 26(10):1253-61. PubMed ID: 1330097
    [Abstract] [Full Text] [Related]

  • 72. Safety and effectiveness of azithromycin in the treatment of respiratory infections in children.
    Lakoš AK, Pangerčić A, Gašparić M, Kukuruzović MM, Kovačić D, Baršić B.
    Curr Med Res Opin; 2012 Jan 12; 28(1):155-62. PubMed ID: 22070514
    [Abstract] [Full Text] [Related]

  • 73. [Comparative clinical effectiveness and tolerance of azithromycin (sumamed) and erythromycin in patients with sinusitis].
    Strachunskiĭ LS, Tikhonov VG, Kuleshov SE, Asmolovskiĭ VM.
    Antibiot Khimioter; 1993 Jan 12; 38(1):13-6. PubMed ID: 8060176
    [Abstract] [Full Text] [Related]

  • 74. Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications.
    Drew RH, Gallis HA.
    Pharmacotherapy; 1992 Jan 12; 12(3):161-73. PubMed ID: 1319048
    [Abstract] [Full Text] [Related]

  • 75. Respiratory infections in children: when is brodimoprim indicated?
    Herz G.
    J Chemother; 1993 Dec 12; 5(6):556-61. PubMed ID: 8195857
    [Abstract] [Full Text] [Related]

  • 76. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
    Langtry HD, Brogden RN.
    Drugs; 1997 Jun 12; 53(6):973-1004. PubMed ID: 9179528
    [Abstract] [Full Text] [Related]

  • 77. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan.
    Hsueh PR, Shyr JM, Wu JJ.
    Clin Microbiol Infect; 2006 Mar 12; 12(3):296-8. PubMed ID: 16451421
    [Abstract] [Full Text] [Related]

  • 78. [Clinical experience with clarithromycin in the pediatric field].
    Tayama M, Ichioka T, Hosoda T, Miyao M.
    Jpn J Antibiot; 1989 Feb 12; 42(2):388-92. PubMed ID: 2526251
    [Abstract] [Full Text] [Related]

  • 79. Treatment of lower respiratory infections in outpatients with ofloxacin compared with erythromycin.
    Peugeot RL, Lipsky BA, Hooton TM, Pecoraro RE.
    Drugs Exp Clin Res; 1991 Feb 12; 17(5):253-7. PubMed ID: 1756688
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.